Search Results for "Drug Interactions"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Drug Interactions. Results 41 to 50 of 281 total matches.
Cabtreo: A Three-Drug Gel for Acne
The Medical Letter on Drugs and Therapeutics • Apr 15, 2024 (Issue 1700)
of skin
(avoiding the nipple and areola) and for the shortest
duration possible.
DRUG INTERACTIONS ...
The FDA has approved Cabtreo (Bausch Health), a gel
containing the retinoid adapalene, the oxidizing agent
benzoyl peroxide, and the antibiotic clindamycin, for
treatment of acne vulgaris in patients ≥12 years old.
Cabtreo is the first three-drug topical formulation to
become available in the US for treatment of acne.
Med Lett Drugs Ther. 2024 Apr 15;66(1700):59-60 doi:10.58347/tml.2024.1700b | Show Introduction Hide Introduction
Drugs for Sexually Transmitted Infections
The Medical Letter on Drugs and Therapeutics • Jun 27, 2022 (Issue 1653)
Drugs for Sexually Transmitted Infections ...
This article includes recommendations for management
of most sexually transmitted infections (STIs)
other than HIV and viral hepatitis. Some of the
indications and dosages recommended here have
not been approved by the FDA (see Table 1).
In Brief: Three New Injectable Antipsychotic Drugs
The Medical Letter on Drugs and Therapeutics • Dec 25, 2023 (Issue 1692)
adjustments may be needed for renal or hepatic impairment or for drug interactions.
2. Initial dosage of long ...
Three extended-release injectable formulations of
second-generation antipsychotic drugs — two of
risperidone (Rykindo, Uzedy) and one of aripiprazole
(Abilify Asimtufii) — have been approved by the FDA
for treatment of schizophrenia in adults. Rykindo and
Abilify Asimtufii are also approved for maintenance
treatment of bipolar I disorder in adults. Other
extended-release injectable formulations of
risperidone and aripiprazole have been available in
the US for years (see Table 1).
Med Lett Drugs Ther. 2023 Dec 25;65(1692):207-8 doi:10.58347/tml.2023.1692d | Show Introduction Hide Introduction
Drugs for Inflammatory Bowel Disease
The Medical Letter on Drugs and Therapeutics • Jul 10, 2023 (Issue 1680)
adverse effects have been reported and it interacts
with many other drugs.
Crohn’s Disease (CD ...
Ulcerative colitis (UC) and Crohn's disease (CD),
referred to collectively as inflammatory bowel disease
(IBD), are chronic immune-mediated inflammatory
conditions. Guidelines for treatment of UC and CD
have been updated in recent years
Med Lett Drugs Ther. 2023 Jul 10;65(1680):105-12 doi:10.58347/tml.2023.1680a | Show Introduction Hide Introduction
Comparison Table: Drugs for Alzheimer’s Disease (online only)
The Medical Letter on Drugs and Therapeutics • Aug 22, 2022 (Issue 1657)
for Alzheimer’s Disease
Drug/Formulations Cost1 Adult Dosage Adverse Effects Drug Interactions Comments ...
View the Comparison Table: Drugs for Alzheimer's Disease
Drugs for Atopic Dermatitis
The Medical Letter on Drugs and Therapeutics • Jun 15, 2020 (Issue 1600)
malignancies, and interacts with
many other drugs.
Pregnancy and Lactation – Cyclosporine use during ...
Atopic dermatitis (AD; also known as eczema) is
frequently associated with other atopic disorders
such as allergic rhinitis, asthma, and food allergy. It
commonly presents in infancy and early childhood
and has a relapsing course, often improving by
adolescence, but sometimes persisting into (or first
appearing in) adulthood or even old age.
Two Drugs for Sickle Cell Disease: Crizanlizumab (Adakveo) and Voxelotor (Oxbryta)
The Medical Letter on Drugs and Therapeutics • Apr 06, 2020 (Issue 1595)
adjustments may be needed for hepatic or renal impairment or drug interactions.
2. Approximate WAC for one ...
The FDA has approved two new drugs for sickle cell
disease: crizanlizumab-tmca (Adakveo – Novartis), an
IV P-selectin blocker, and voxelotor (Oxbryta – GBT),
an oral hemoglobin S (HbS) polymerization inhibitor.
Comparison Table: Some Drugs for Maintenance Treatment of Opioid Use Disorder (online only)
The Medical Letter on Drugs and Therapeutics • Sep 04, 2023 (Issue 1684)
Formulations
Target Maintenance
Dosage Adverse Effects Drug Interactions Pregnancy/Lactation Comments Cost1 ...
View Comparison Table: Some Drugs for Maintenance Treatment of Opioid Use Disorder
Med Lett Drugs Ther. 2023 Sep 4;65(1684):e144-5 doi:10.58347/tml.2023.1684b | Show Introduction Hide Introduction
Antibacterial Drugs for Community-Acquired Pneumonia
The Medical Letter on Drugs and Therapeutics • Jan 25, 2021 (Issue 1616)
and
torsades de pointes.8
DRUG INTERACTIONS — Coadministration of antacids
or products containing calcium ...
Treatment of community-acquired pneumonia (CAP)
is usually empiric, with selected antibiotic regimens
directed against some of the most common causative
pathogens. Recommended empiric regimens are
listed in Table 2; recommended antibiotic dosages for
treatment of CAP are listed in Tables 3 and 4. Joint
guidelines for treatment of CAP by the American
Thoracic Society and the Infectious Diseases Society of
America (ATS/IDSA) were updated in 2019.
Comparison Chart: Antiviral Drugs for Influenza for 2023-2024 (online only)
The Medical Letter on Drugs and Therapeutics • Nov 13, 2023 (Issue 1689)
within 10 hours after reconstitution
DRUG INTERACTIONS
DURATION OF THERAPY
TREATMENT:
Oseltamivir ...
View the Comparison Chart: Antiviral Drugs for Influenza for 2023-2024
Med Lett Drugs Ther. 2023 Nov 13;65(1689):e1-6 doi:10.58347/tml.2023.1689e | Show Introduction Hide Introduction